Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease

Many prognostic models for cardiovascular risk can be used to estimate aspirin's absolute benefits, but few bleeding risk models are available to estimate its likely harms.To develop prognostic bleeding risk models among persons in whom aspirin might be considered for the primary prevention of cardiovascular disease (CVD).Prospective cohort study.New Zealand primary care.The study cohort comprised 385 191 persons aged 30 to 79 years whose CVD...